Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Mar 3;18(3):e1010091. doi: 10.1371/journal.pgen.1010091

Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response

Jeremy T Florman 1, Mark J Alkema 1,*
Editor: Kaveh Ashrafi2
PMCID: PMC8932558  PMID: 35239681

Abstract

Co-localization and co-transmission of neurotransmitters and neuropeptides is a core property of neural signaling across species. While co-transmission can increase the flexibility of cellular communication, understanding the functional impact on neural dynamics and behavior remains a major challenge. Here we examine the role of neuropeptide/monoamine co-transmission in the orchestration of the C. elegans escape response. The tyraminergic RIM neurons, which coordinate distinct motor programs of the escape response, also co-express the neuropeptide encoding gene flp-18. We find that in response to a mechanical stimulus, flp-18 mutants have defects in locomotory arousal and head bending that facilitate the omega turn. We show that the induction of the escape response leads to the release of FLP-18 neuropeptides. FLP-18 modulates the escape response through the activation of the G-protein coupled receptor NPR-5. FLP-18 increases intracellular calcium levels in neck and body wall muscles to promote body bending. Our results show that FLP-18 and tyramine act in different tissues in both a complementary and antagonistic manner to control distinct motor programs during different phases of the C. elegans flight response. Our study reveals basic principles by which co-transmission of monoamines and neuropeptides orchestrate in arousal and behavior in response to stress.

Author summary

Co-transmission is a form of neuronal communication where multiple signaling molecules are released from an individual cell. It is commonly found in nervous systems across species that monoamines and neuropeptides are co-released and affect the properties of target cells. In humans, adrenaline and neuropeptide Y are co-released from sympathetic neurons where they increase blood pressure and heart rate during the fight-or-flight response. The complexity of the human nervous system makes it very hard to figure out how these signaling molecules interact to change behavior and physiology. Here, we use the nematode C. elegans to study how co-transmission of the invertebrate analog of adrenaline, tyramine, and a neuropeptide, FLP-18, coordinate the distinct motor programs of the flight response. We find that FLP-18 and tyramine act together to shape different phases of the flight response. Our findings illuminate the cellular mechanisms by which co-transmission of monoamines and neuropeptides orchestrate a flight response.

Introduction

Co-localization of classical neurotransmitters and neuropeptides is a common feature of the animal nervous system [1]. Co-transmission is thought to provide flexibility to the output of hard-wired neural circuits [2]. In mammals, for instance, the acute fight-or-flight response leads to the activation of the sympathetic nervous system (SNS) and the co-release of different “stress hormones” [3]. Adrenalin and noradrenaline release in the SNS trigger an increase in heart rate, blood flow, respiration and release of glucose from energy stores, which prepare the animal for vigorous muscle activity and physical exertion [4,5]. Neuropeptide Y (NPY), one of the most abundant neuropeptides in the mammalian nervous system, is a co-transmitter with noradrenaline (NA) in many neurons of the SNS [68]. The sympathetic co-transmission of NA and NPY suggest that they may coordinate aspects of the flight response. However, the physiological and behavioral impact of co-transmission can be difficult to dissect. Co-transmitted signaling molecules can activate receptors on a common target (convergence) or different targets (divergence) which induce synergistic or opposing effects, making the functional outcome of co-transmission challenging to anticipate. Studies in mammals have shown that the stress related modulatory functions of NPY and NA co-transmission are complex, with complementary actions in some tissues and antagonistic actions in others. For example, both NA and NPY increase blood pressure through peripheral vasoconstriction, however NPY inhibits presynaptic NA release from sympathetic neurons and opposes the action of NA on cardiac contraction [919]. Co-transmission of NPY and catecholamines may induce a longer lasting state of arousal that enhances alertness and the ability to deal with environmental threats. Unraveling the precise effects of co-transmission of neural stress hormones is very challenging in vertebrates given the complexity of the nervous system, the multiple central and peripheral release sites and the diversity of target tissues expressing NA and NPY receptor (NPYR) subtypes.

The nematode Caenorhabditis elegans provides an excellent system to study the co-transmission of aminergic and peptidergic neuromodulators due to its compact and completely defined nervous system and wealth of genetic tools [20,21]. The C. elegans genome encodes a large family of NPY related peptides and G-protein coupled receptors (GPCRs) [22,23]. Like other invertebrates, C. elegans lacks NA, however the structurally related tyramine fulfills a similar role to NA in coordinating stress responses and flight behavior [2426].

In response to a mechanical stimulus C. elegans can engage in a flight- or an escape-response, where the worm quickly reverses while suppressing oscillatory head movements. The reversal is followed by a deep ventral bend of the head, and a subsequent slide of the head along the ventral side of the body (omega turn). After the omega turn, the animal moves forward in the opposite direction, away from the noxious stimulus. Tyramine plays a crucial role in the coordination of independent motor programs, which increases the animal’s chances to escape from predatory fungi that use hyphal nooses to entrap nematodes [2629]. The escape response triggers the release of tyramine from a single pair of neurons called the RIM. Tyramine release activates the inhibitory tyramine-gated chloride channel, LGC-55, in neck muscles, cholinergic head motor neurons and the AVB pre-motor interneuron. LGC-55 activation induces the suppression of oscillatory head movements during long reversals in response to anterior touch [26,28,30,31]. In addition, tyramine release facilitates ventral bending during the omega turn through the activation of the SER-2 GPCR in GABAergic motor-neurons [29]. The tyraminergic RIM neurons co-express a NPY like peptide, FLP-18 [32,33]. The RFamide FLP-18 and its associated receptors are related to the NPY/NPYR signaling system [34]. In vitro experiments have shown that FLP-18 can activate a human NPYR and, conversely, human NPY can activate worm neuropeptide receptors [35]. In C. elegans, FLP-18 has been shown to play a role in foraging and metabolism [36], arousal and homeostasis [3739], chemosensation [40], reversal behavior [41,42], and swimming [33,43]. FLP-18 acts through several neuropeptide receptors including NPR-1, NPR-4, and NPR-5 [32,36,44].

Here we investigate the role of FLP-18 in the orchestration of the C. elegans escape response. We find that FLP-18 plays a central role in coordinating distinct phases of the escape response in C. elegans. FLP-18 is co-released with tyramine from the RIM neurons in response to mechanical stimuli. FLP-18 activates the GPCR NPR-5 in body wall muscle to enhance turning behavior and locomotion speed during the escape response by increasing muscle excitability. Our result show that FLP-18 and tyramine act in different tissues in both a complementary and antagonistic manner to orchestrate distinct motor programs during different phases of the C. elegans flight response.

Results

Mechanical stimulation transiently increases forward velocity

Handling of C. elegans, such as the transfer with a platinum wire, bumping the plate on microscope stage or removing the lid of a plate can induce an increase in locomotion rate that persists for several minutes [45,46]. This indicates that mechanical stimulation can lead to longer lasting changes to the internal state of the animal. To quantify locomotion patterns upon mechanical stimulation we analyzed the locomotion rate of animals subjected to a tap to the side of the plate. Mechanical tap can trigger an escape response, in which C. elegans reverses, turns and resumes forward locomotion in the opposite direction [47,48]. We compared behavior of animals before, during and after spontaneous reversals and tap-induced reversals. In animals that initiated a spontaneous reversal, forward locomotion rate remained the same before and after the reversal (Fig 1A). The absolute velocity during spontaneous reversals was similar to the velocity of forward movement.

Fig 1. Increase in locomotion speed following a mechanical stimulus.

Fig 1

Backward- and forward-velocity upon a spontaneous or tap-induced reversal. Wild-type animals show a persistent increase in locomotion speed in response to a strong tap stimulus (“forward run”). flp-18 mutants do not show a robust increase locomotion speed in response to a strong tap stimulus. (A-B) Schematic illustrating behavioral sequence (top) and velocity traces (bottom) from wild type animals, flp-18, and tdc-1 mutants, aligned to reversal events. Negative velocity indicates backward locomotion. Dark lines represent mean velocity and shaded region represents standard error. Black lines at the top of the graph indicate the time periods when reversal and forward run speed were quantified. Reversals were spontaneous (A) or induced by a tap stimulus (B). (C) Peak backward velocity during the reversal phase was quantified by identifying the maximum backward locomotion rate for each animal during a 1 second period following the tap. (D) Forward run velocity was quantified as the average speed for each animal during the time period between 7 to 10 seconds following the tap. (E) Quantification of the percentage of animals initiating a reversal within 1 second after a tap was delivered. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s (C and D) and Dunnett’s (E) multiple comparison test (P> 0.05 = ns, P<0.005 = **, P<0.0001 = ****). Sample sizes: Spontaneous reversals and escape response (A-D), (n = # animals). Spontaneous (A, C, and D): wild type (n = 506), flp-18 (n = 512), tdc-1 (n = 512). Escape (b-d): wild type (n = 275), flp-18 (n = 208), tdc-1 (n = 124). % Reversing (E), (n = # of experiments, 20 worms per experiment): wild type (n = 30), flp-18 (n = 23), tdc-1 (n = 11).

When an escape response was triggered with a tap stimulus, animals initiated a rapid reversal; double the speed of spontaneous reversals (Fig 1B and 1C). Furthermore, following a tap-induced reversal, wild-type animals exhibited a markedly elevated forward locomotion rate for approximately 3 minutes (S1A Fig);—a behavior we refer to as the ‘forward run’ (Fig 1B and 1D). The sustained increase in forward velocity in response to a tap indicated longer lasting changes in the internal state of the animal.

flp-18 mutants have defects in locomotory arousal

Neuropeptides are potent neuromodulators, whose action can lead to longer lasting changes in behavior. We focused our attention on FLP-18 neuropeptides, since the flp-18 gene is known to be expressed in the tyraminergic RIM neurons and the AVA pre-motor interneurons [32,33]. The RIM and AVA play a central role in the escape response to mechanical touch [25,26,47,49]. flp-18 mutants and tyramine deficient tdc-1 mutants initiated reversals in response to tap stimuli similar to wild type (Fig 1E). This indicates that FLP-18 peptides and tyramine are not required for mechanosensation or the initiation of the escape response. In response to a tap stimulus, flp-18 mutants reversal velocity was slightly reduced compared to wild type and tdc-1 mutant animals (Fig 1B and 1C). Both flp-18 and tdc-1 mutants exhibited shorter reversal duration compared to wild type (Fig 1B). tdc-1 mutants had a reduced basal velocity, but following a tap, increased velocity during the forward run, similar to the wild type. In contrast, flp-18 mutants had significantly slower forward run velocity compared to the wild type (Fig 1B and 1D). tdc-1; flp-18 double mutants behaved similar to tdc-1 single mutants during the initial phase of the escape response and like flp-18 single mutants failed to maintain forward velocity at later stages of the forward run (S1B Fig).

flp-18 mutants have defects in head and body bending during the escape response

Under regular conditions flp-18 mutants had no obvious defects in locomotion velocity, body curvature, foraging head movements, or spontaneous reversal frequency (Fig 2A–2F) and propagated regular body bends as they moved across the agar surface (Fig 2G). We analyzed flp-18 mutant animals for defects in other aspects of the escape response, since flp-18 mutants fail to sustain rapid movement during the forward run. During the initial phase of the escape response elicited by gentle anterior touch, animals reverse while suppressing oscillatory head movements. The reversal is often followed by two linked motor programs that together compose an omega turn: a ventral head swing which initiates the omega turn; followed by a deep body bend where the animal slides its head along the ventral side of the body to resume locomotion in the opposite direction. In response to gentle anterior touch flp-18 mutants reversed and suppressed oscillatory head movements like the wild type (Fig 3E). Following a reversal, flp-18 mutants often initiate an omega turn similar to the wild type. However, flp-18 mutants made shallower ventral head bends (Fig 3B) and executed omega turns (> 90-degree turn) less frequently than wild-type animals (37% vs 57% respectively) (Fig 3C). Furthermore, when flp-18 mutants did make high-angled omega turns, the head often failed to contact the ventral side of the body during the turn [29] (Fig 3A) resulting in a much higher proportion of open omega turns compared to wild-type animals (62% vs 22% respectively) (Fig 3D). Expression of a low-copy transgenic flp-18 genomic construct, which includes a 3 kb endogenous promoter ([Pflp-18::FLP-18], referred to as FLP-18(+)), rescued the omega turning defects seen in flp-18 mutants (Fig 3C–3E).

Fig 2. Overexpression of FLP-18 causes locomotion defects.

Fig 2

(A) Behavioral tracking of wild type, flp-18(gk3063) mutants, and transgenic animals that overexpress FLP-18 (FLP-18(+++)). Representative images of each genotype (upper panel) and locomotion tracks recorded from multiple animals freely moving on a plate for 5 min (lower panel). Scale bars represent 200 μm (top) and 5 mm (bottom). (B) Schematic illustrating quantified behaviors. (C-F) Quantification of locomotion behavior. (C) Speed of foraging head movements. (D) locomotion velocity. (E) Body bend curvature. (F) Spontaneous reversal frequency. (G) Kymographs showing body bending along the body over 30 s of locomotion. Color map represents degrees of bending, positive values represent dorsal bends and negative values represent ventral bends. Graphs represent mean ± SEM, significance was calculated using ANOVA with Dunnett’s multiple comparison test (P<0.005 = **, P<0.0001 = ****). Sample sizes: (C), wild type (n = 38), flp-18 (n = 28), FLP-18(+++) (n = 31). (D-F) wild type, flp-18, and FLP-18(+++) (n = 16 experiments per genotype, 20 animals per experiment).

Fig 3. flp-18 mutants are defective in head bending and turning during the escape response.

Fig 3

(A) Schematic depicting head oscillations, ventral turn head angle and open vs closed omega turns. (B) Angle of ventral head bend following touch induced reversal of animals that make omega turns (probability histogram with a bin size of 15°). Each concentric circle represents a probability of 0.1. (C-D) Quantification of omega turning behavior. (C) Percentage of animals that execute omega turns in response to gentle anterior touch. (D) Fraction of open omega turns out of total omega turns. (E) Quantification of the percentage of animals suppressing head oscillations upon gentle anterior touch. Mean ± SEM. significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.0005 = ***, P<0.0001 = ****). Sample sizes: Ventral head bend measurement (B) (n = # of animals), wild type (n = 52), flp-18 (n = 30), FLP-18(+++) (n = 58). Suppression of head movement and omega quantification (C-E) (n = # of experiments, 20 worms per experiment) wild type (n = 17), flp-18 (n = 16), flp-18; FLP-18(+) (n = 9), FLP-18(+++) (n = 10).

flp-18 overexpression enhances body bending and omega turning

To further assess the effect of FLP-18 signaling on behavior we overexpressed flp-18 using a high-copy transgene ([Pflp-18::FLP-18], referred to as FLP-18(+++)). flp-18 overexpression caused uncoordinated locomotion with strikingly deep body bends (Fig 2A and 2G) consistent with previous reports [32]. Animals overexpressing flp-18 also displayed hyperactive foraging head movements, increased body curvature, and increased spontaneous reversal frequency (Fig 2C–2F). flp-18 reporters are expressed in the AVA, RIM, AIY, RIG, the M1 and M3 pharyngeal neurons and ventral cord motor neurons [32,33,39]. We overexpressed flp-18 in a subset of neurons of the escape circuit using the cex-1 promoter, which mainly drives expression in the RIM, AVA and AVD neurons [50], but not the AIY, RIG, pharyngeal and ventral cord neurons (S2A Fig). Overexpression of the Pcex-1::FLP-18 transgene in a flp-18 mutant background was sufficient to cause exaggerated body bends and reversals, similar to Pflp-18::FLP-18 transgenic animals (S2B–S2D Fig and S1 and S2 Videos). This indicates that FLP-18 release from the escape circuit neurons, AVA, RIM and AVD, is sufficient to enhance body bending and reversals.

FLP-18 overexpression had an opposite effect on the escape response compared to flp-18 deficiency. In contrast to flp-18 mutants, which have reduced ventral head bend angle, FLP-18 overexpressing animals made high angled head bends (Fig 3B). Furthermore, overexpression of FLP-18 resulted in an increased omega turn frequency and a reduced proportion of open omega turns (Fig 3C and 3D). Moreover, in response to a mechanical stimulus FLP-18 overexpressing animals failed to suppress head movements during reversals (Figs 3E and S3 and S3 and S4 videos). This phenotype is similar to tyramine deficient mutants (S1C Fig) and mutants that lack a tyramine-gated chloride channel, LGC-55 [26,28,30]. In wild-type animals, suppression of head oscillations during touch induced reversals is mediated by tyraminergic activation of LGC-55 in neck muscles and SMD and RMD head motor-neurons. The observation that animals overexpressing FLP-18 fail to suppress head movements suggests that FLP-18 may oppose the tyraminergic inhibition of neck muscles.

The escape response induces FLP-18 release from the AVA and RIM

flp-18 is expressed in the AVA and RIM neurons [32,33], which are activated during the escape response [25,49,51]. To analyze FLP-18 release, we generated transgenic animals with a fluorescently tagged the FLP-18 pro-peptide with the YFP variant Venus (Pflp-18::FLP-18::Venus). Venus is resistant to quenching in low pH environments and has been used to monitor neuropeptide secretion from dense core vesicles in C. elegans [5254]. FLP-18::Venus fluorescence was observed in the RIM and AVA escape circuit neurons, as well as the AIY and RIG (Fig 4B). FLP-18::Venus fluorescence was also observed in the coelomocytes, in contrast to a Pflp-18::GFP transcriptional reporter which did not produce detectable coelomocyte fluorescence [32]. This is consistent with the idea that FLP-18::Venus protein is secreted and taken up by coelomocytes, which are endocytic scavenger cells that internalize material from the pseudocoelomic fluid [55]. We measured changes in fluorescent intensity in the AVA and RIM neurons after repeated activation of the escape response (Fig 4A and 4C). Mechanical tap to the plate caused a progressive reduction in FLP-18::Venus fluorescent intensity in the AVA and RIM neurons compared to animals that did not receive the tap stimuli (Fig 4D and 4E), suggesting that activation of the escape response elicits the release of FLP-18 from the AVA and RIM. Tap treatment did not change the fluorescent intensity in coelomocytes (Fig 4F). This could be due to protein break down in the coelomocytes and/or the high basal levels of coelomocyte fluorescence due to tonic FLP-18 release from other neurons.

Fig 4. The escape response stimulates FLP-18 release from the AVA and RIM.

Fig 4

Animals expressing a FLP-18::Venus fusion protein were subjected to repeated mechanical plate taps. The decrease in fluorescent intensity of the RIM and AVA cell bodies and the anterior-most coelomocyte were quantified as a readout of FLP-18 release. (A) Schematic illustrating the processing and exocytosis of the FLP-18::Venus fusion protein. (B) Representative image showing an animal expressing FLP-18::Venus, DIC and GFP overlay. Scale bar represents 10 μm. (C) Average velocity of a population of animals as they are subjected to mechanical plate taps. Green arrows indicate the delivery of a tap every 2 min. The spikes in velocity coincide with the initiation of the escape response (D-E) Quantification of fluorescence (arbitrary units–a.u.) in the AVA (D), RIM (E), and coelomocytes (F), at 0-, 1- and 2-hour time points. Graphs represent mean ± SEM, significance was calculated using ANOVA with Dunnett’s multiple comparison test (P<0.005 = **, P<0.0005 = ***, P<0.0001 = ****). Sample size: (C) n = 3 replicates, >30 animals per replicate. (D-F) Control (n = 32), Tap 1 hr. (n = 26), Tap 2 hr. (n = 35).

FLP-18’s modulation of the escape response depends on npr-5

How does FLP-18 signaling modulate locomotion and the escape response? FLP-18 peptides activate the GPCRs: NPR-1, NPR-4 and NPR-5 in vitro [32,36,44]. We analyzed npr-1, npr-4, and npr-5 loss-of-function mutants for defects in the escape response. npr-1, npr-4 and npr-5 mutants displayed largely normal locomotion and initiated an escape response upon anterior touch. While loss of npr-1 or npr-4 had no impact on the frequency of omega turns, npr-5 mutants executed fewer omega turns compared to the wild type (Fig 5A). The decrease in omega turning of npr-5 mutants was comparable to flp-18 mutants. Furthermore, like flp-18 mutants, npr-5 mutants also display a higher proportion of open omega turns (Fig 5B). This suggests that FLP-18 peptides released during the escape response enhance head and body bending to promote turning through activation of the GPCR NPR-5.

Fig 5. Loss of npr-5 impedes omega turning and suppresses FLP-18 overexpression phenotypes.

Fig 5

Overexpression of FLP-18 causes uncoordinated locomotion, frequent reversals, and excessive bending, which is suppressed in an npr-5 mutant background. (A-B) Quantification of omega turning behavior. (A) Percentage of animals that execute omega turns in response to gentle anterior touch. (B) Fraction of open omega turns out of total omega turns. (C and D) Mean body curvature averaged over 5 seconds prior to a tap stimulus (C) or immediately following a strong tap stimulus (D). (E) Percentage of animals suppressing head movements in response to gentle anterior touch with an eyelash. (F and G) Omega turning behavior in FLP-18 overexpressors. (F) Percentage of animals initiating omega turns after gentle anterior touch. (G) Proportion of open omega turns out of total omega turns. (H) Mean number of spontaneous reversals per minute per worm averaged over 3 minutes. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P> 0.05 = ns, P<0.05 = *, P<0.005 = **, P<0.0005 = ***, P<0.0001 = ****). Sample sizes (n = # of experiments, 20 animals per experiment): Omega turn quantification (A and B) wild type (n = 21), flp-18 (n = 21), npr-1 (n = 12), npr-4 (n = 14), npr-5 (n = 21). Curvature and reversal measurements (C, D, and H) wild type (n = 46), FLP-18(+++) (n = 33), npr-1; FLP-18(+++) (n = 23), npr-4; FLP-18(+++) (n = 27), npr-5; FLP-18(+++) (n = 23). Suppression of head movements and omega turn quantification (E-G) wild type (n = 22), FLP-18(+++) (n = 10), npr-1; FLP-18(+++) (n = 12), npr-4; FLP-18(+++) (n = 10), npr-5; FLP-18(+++) (n = 10).

Next, we examined whether neuropeptide receptor mutants could suppress the hyper bending phenotype of the FLP-18 overexpression strain. Mutations in either npr-1, npr-4 or npr-5 alone had no effect on body curvature during basal locomotion (S4A Fig). In the FLP-18(+++) background, deletion of npr-5, but not npr-1 or npr-4, restored body curvature to wild-type levels (Fig 5C). Loss of npr-5 also suppressed the hyper bending during the omega turn caused by FLP-18 overexpression (Figs 5D and S4B). npr-5; FLP-18(+++) animals make omega turns similar to wild type (Fig 5F). However, the proportion of open omega turns made by npr-5; FLP-18(+++) animals is significantly increased and similar to npr-5 single mutants (Fig 5G).

npr-1; FLP-18(+++) and npr-4; FLP-18(+++) were indistinguishable from FLP-18(+++) in their failure to suppress head oscillations in response to touch. In contrast, npr-5; FLP-18(+++) animals suppressed head movements in response to anterior touch like wild-type animals (Fig 5E). Loss of both npr-1 and npr-5 reduced the high spontaneous reversal frequency caused by FLP-18 overexpression (Fig 5H). npr-1 single mutants displayed significantly fewer spontaneous reversals compared to wild-type animals (S4C Fig), likely due to the fact that npr-1 mutants avoid ambient oxygen concentrations [56]. Under low oxygen conditions loss of npr-1 failed to suppress the increased reversal frequency caused by FLP-18 overexpression (S4D Fig). This suggests that the effect of npr-1 on reversal frequency reflects its role in oxygen sensation independent of npr-5. We further analyzed npr-5 mutants for locomotion defects during the escape response. Tap-stimulated peak reversal velocity was slightly reduced in npr-5 mutants. In addition, there was a marked decrease in forward run speed (Fig 6A–6D), closely resembling the defect observed in flp-18 mutants. Taken together these data indicate that FLP-18 modulates locomotory arousal in the escape response primarily through the activation of the NPR-5 receptor.

Fig 6. npr-5 mutants have defects in forward run speed, body bending and reversal frequency.

Fig 6

(A-B) Schematic illustrating behavioral sequence (top) and velocity traces (bottom) from wild type and npr-5 mutants aligned to reversal events, backward locomotion is negative. Dark lines represent mean velocity and shaded region represents standard error. Reversals were spontaneous (A) or induced by a tap stimulus (B). (C) Peak reversal velocity during the first second following the tap stimulus. (D) Mean locomotion velocity during the forward run phase (t = 7-10s). (E) Confocal images of animals expressing an NPR-5::GFP translational fusion protein: zfEx852 [Pnpr-5::NPR-5::GFP]. Upper panel: Z-projection shows strongest expression in head- and neck-muscles and muscle arms. NPR-5::GFP localizes to body-wall and vulval muscle. Body wall muscle arms are visible (arrow heads). Lower left panel: confocal slice showing NPR-5::GFP localization to dense bodies in head muscle. Lower right panel: Z-projection showing high expression in head- and neck- muscle arms and in the muscle plate in the nerve ring (asterisk). Neuronal cell bodies that express NPR-5::GFP are indicated by arrows. Scale bars represent 25 μm. (F-H) Behavioral analysis of NPR-5 overexpression, either from its endogenous promoter (Pnpr-5) or from a muscle specific promoter (Pmyo-3). Mean body curvature averaged over 5 seconds prior to (F), or immediately following (G), a tap stimulus. (H) Quantification of spontaneous reversal frequency. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P>0.05 = ns, P<0.005 = **, P<0.0005 = ***, P<0.0001 = ****). Sample sizes: (A-C) (n = # of animals), wild type (n = 512), npr-5 (n = 258). (F-H) (n = # of experiments, 20 animals per experiment). wild type (n = 20), FLP-18(+++) (n = 13), Pnpr-5::NPR-5 (n = 12), Pmyo-3::NPR-5 (n = 14).

NPR-5 acts in head-, neck and body wall muscle to drive body bending

To analyze where NPR-5 acts we generated transgenic animals that express a GFP tagged NPR-5 translational fusion [Pnpr-5::NPR-5::GFP]. NPR-5::GFP expression was detected in head, neck, and body-wall muscle (Fig 6E), and in a few neuronal cell bodies in the head (Fig 6E, lower right panel), consistent with previously described transcriptional reporters for npr-5 [36]. NPR-5::GFP expression was particularly strong in head- and neck-muscles. We found that NPR-5::GFP localizes to dense bodies within muscle cells and is highly enriched in muscle arms and the muscle plate around the nerve ring (Fig 6E). The neck muscle arms around the nerve ring receive direct synaptic inputs from the FLP-18 expressing RIM neurons [20]. Overexpression of NPR-5 under control of the endogenous promoter (Pnpr-5::NPR-5) did not cause elevated curvature during basal locomotion (Fig 6F). However, in response to a mechanical stimulus, Pnpr-5::NPR-5 animals displayed increased body curvature comparable to FLP-18(+++) animals (Fig 6G). This suggests that the effect of NPR-5 overexpression driven by the endogenous promoter is uncovered when FLP-18 is released during the escape response. Cell-specific overexpression of NPR-5 in all body wall muscles (including head- and neck-muscles; Pmyo-3::NPR-5), on the other hand, did increase body curvature during both basal and tap-induced locomotion, similar to FLP-18 overexpressors (Fig 6F and 6G). The discrepancy in basal curvature between the Pnpr-5::NPR-5 and Pmyo-3::NPR-5 transgenic animals may be due to differences in NPR-5 expression pattern and/or level. Pmyo-3 is expressed strongly in all body wall muscle, while expression of the endogenous Pnpr-5 promoter is restricted to a subset of neurons and is high in head- and neck-muscles. Overexpression of NPR-5 under control of its endogenous promotor increased spontaneous reversal frequency, similar to FLP-18 overexpressing animals. Muscle specific expression of NPR-5 did not increase reversals (Fig 6H). Consistent with previous observations, this may suggest that neuronal expression of NPR-5 modulates reversal behavior [42]. Our results indicate that FLP-18 acts through NPR-5 in muscle to enhance body bending.

FLP-18 increases calcium levels in body wall muscle

How does FLP-18 stimulate body bending? Muscle contractions are triggered by the rapid entry of calcium into the muscle cytosol [57,58]. To determine if FLP-18 signaling affects calcium levels in body wall muscle we generated a strain expressing the fluorescent calcium indicator GCaMP6s in body wall muscles [Pmyo-3::GcaMP6] (Fig 7A). C. elegans locomotion is driven by alternating waves of contraction and relaxation in dorsal and ventral muscles. During locomotion the highest GCaMP fluorescence was observed when muscles were contracted and faded upon relaxation, consistent with calcium influx driving muscle contraction (Fig 7A). flp-18 mutants showed a reduction in GCaMP fluorescence in the muscle (Fig 7B). In sharp contrast, overexpression of FLP-18 resulted in a striking increase of GCaMP fluorescence in body-wall muscles (Fig 7A and 7B). This indicates that FLP-18 increases calcium transients in muscles that facilitate body bending.

Fig 7. FLP-18 increases muscle calcium levels and requires NPR-5 and EGL-30/Gαq.

Fig 7

(A) Loss of flp-18 or npr-5 reduces calcium transients in body wall muscle. FLP-18 overexpression causes a large increase in muscle GCaMP6 fluorescence, which is suppressed by loss of npr-5 or egl-30. Representative images of animals expressing a Pmyo-3::GCaMP6 transgene in different genetic backgrounds. Grayscale images have been recolored for visibility. Pixel intensity values (arbitrary units) and corresponding colormap are depicted in the color bar to the left of images. Scale bar represents 200 μm. (B) Quantification of mean GCaMP6 fluorescence in body wall muscle in different genetic backgrounds. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.0001 = ****). Sample size for each genotype is indicated at the base of each bar.

Like flp-18 mutants, npr-5 mutants displayed a similar decrease in GCaMP fluorescence in body wall muscles. Furthermore, an npr-5 mutation completely suppressed the increase in GCaMP fluorescence of FLP-18 overexpression (Fig 7B). In vitro experiments indicate that NPR-5 signals primarily through the Gαq pathway [44]. Activation of Gαq coupled receptors can cause the release of calcium from intracellular stores [59,60]. egl-30 encodes the main C. elegansq ortholog [61]. To determine whether in vivo NPR-5 signaling is Gαq dependent we examined the effect of mutations in egl-30 on muscle calcium levels. Loss of egl-30 substantially decreased GCaMP fluorescence in muscle. GCaMP fluorescence was also strongly reduced in the muscles of egl-30; FLP-18(+++) animals and indistinguishable from egl-30 single mutants (Fig 7B). Mutations in FLP-18 signaling genes did not affect intensity of a co-expressed Ca2+ insensitive fluorophore (S5A and S5B Fig) indicating that the differences in GCaMP fluorescence are due to altered intracellular Ca2+ levels. Our results support the idea that FLP-18 activates NPR-5 and EGL-30/Gαq signaling cascades, resulting in increased calcium levels in the muscle (Fig 8B).

Fig 8. Model: FLP-18 / tyramine co-transmission in the choreography of escape behavior.

Fig 8

Schematic depicting the effects of tyramine and FLP-18 on behavior (A) and the underlying molecular pathway (B). Touch leads to the activation of the AVA (not pictured) and RIM neurons resulting in the release of FLP-18 and tyramine (RIM only) during the escape response. Tyramine activates LGC-55 chloride channels which hyperpolarize AVB neurons and neck muscle. Hyperpolarization of the AVB suppresses forward locomotion, indirectly increasing reversal length, while hyperpolarization of neck muscle leads to the suppression of head oscillations (SHO) during the reversal. Tyramine also activates the Gαo coupled SER-2 receptor in GABAergic VD motor neurons enhancing ventral bending during the omega turn. FLP-18 activates NPR-5 in neck and body wall muscle resulting in an EGL-30/Gαq mediated Ca2+ influx. FLP-18 antagonizes the effect of tyramine in neck muscles, facilitating the re-initiation of head movements following the omega turn. FLP-18 and tyramine act synergistically on divergent targets to orchestrate the omega turn. FLP-18 increases forward run velocity in an NPR-5 dependent manner. See text for details.

Discussion

FLP-18 enhances motor output through the activation of NPR-5

In this study we identify FMRFamide-like peptides encoded by the flp-18 gene as key modulators of the distinct phases in the C. elegans escape response. We showed that FLP-18 neuropeptides are released from the RIM and AVA neurons during an escape response elicited by a mechanical stimulus. FLP-18 promotes head and body bending during the omega turn and increases forward run velocity following the turn. We find that the effects of FLP-18 on locomotion are largely mediated through activation of the Gαq coupled NPR-5 receptor. NPR-5 is highly expressed in head and body wall muscles which receive direct synaptic inputs from the RIM neurons. Studies in both vertebrates and C. elegans have shown that EGL-30/Gαq activates phospholipase Cβ (PLCβ) [62,63]. EGL-8/PLCβ increases IP3 levels which can lead to the release of Ca2+ from internal stores [64,65]. We find that FLP-18 activation of NPR-5 increases calcium levels in muscles in vivo in an EGL-30/Gαq dependent manner. In vitro studies that show that NPR-5 activation by FLP-18 peptides resulted in rises in intracellular Ca2+ levels [44]. Our data support a model in which FLP-18 release during the flight response stimulates Ca2+ release in head and body wall muscle through the NPR-5—EGL-30/Gαq signaling pathway (Fig 8B). Increases in calcium levels would stimulate muscle tension, required for head and body bending the during the omega turn.

Previous studies have indicated that FLP-18 acts in part through NPR-5 in body wall muscles to decrease the convulsion phenotype of nicotinic acetylcholine receptor acr-2(gf) mutants [39]. Our data raise the possibility that a FLP-18 dependent increase in intracellular Ca2+ concentrations may reduce the Ca2+ gradient across the muscle membrane and thus provides a homeostatic response in muscles to the elevated neuronal activity of cholinergic motor-neurons in acr-2(gf) mutants. Recent reports have shown FLP-18 acts through NPR-5 in sensory neurons to control reversal frequency [42]. We found that NPR-5 overexpression using the endogenous promoter (neurons and muscle) increases reversal frequency, while muscle-specific overexpression had no effect. This observation is consistent with a neuronal contribution of NPR-5 in the modulation of reversals. We hypothesize that FLP-18 and NPR-5 mediated increases in muscle Ca2+ levels and excitability contribute to the increase in forward run velocity following the turn. However, we cannot exclude a role for neuronal FLP-18/NPR-5 signaling in the regulation of locomotion rate.

Together, our results show that FLP-18 signaling functions to enhance motor output during the escape response and locomotory arousal through activation of NPR-5 in muscle. FLP-18 thus may contribute a locomotory arousal state that enhances vigilance and the ability to escape from predation. Other studies have shown that FLP-18 activation of NPR-1, dampens the activity of sensory neurons to promote the sleep like quiescent period associated with larval molts [37,38,66,67]. Interestingly, activation of the escape response also induces the release of a distinct RFamide peptide, FLP-20, from mechanosensory neurons. FLP-20 release enhances arousal and motor output across multiple sensory modalities through activation of NPYR like receptor FRPR-3 in the neurosecretory RID neurons [46]. These findings highlight the multilevel nature of RFamide neuropeptides in the modulation of arousal in C. elegans.

Co-transmission of FLP-18 and tyramine orchestrate the flight response

Many neurons contain both small molecule transmitters and neuropeptides. In addition to FLP-18, the RIM neurons also contain additional neuropeptides and the neuromodulator/ neurotransmitter tyramine and glutamate [26,6870]. We have previously shown that tyramine release from the RIM during the escape response coordinates independent motor programs of the escape response [26,28,29]. Our findings indicate that activation of the escape response results in the co-transmission of tyramine and FLP-18 from the RIM. The RIM neurons contain dense core vesicles [71] which can store both neuropeptides and monoamines [72,73]. The RIM also contains regular synaptic vesicles (possibly for the release of glutamate); thus, it is currently unclear whether tyramine and FLP-18 are co-released from the same vesicle. The well-defined escape circuit and the role of the RIM in this response provides the opportunity to dissect of how tyramine and FLP-18 co-transmission choreograph independent motor outputs in the execution of the escape response. Co-transmission of FLP-18 and tyramine from the RIM are convergent in some aspects of the escape response but divergent in others. For example, FLP-18 and tyramine both act to facilitate deep bending during the omega turn but do so through distinct mechanisms in different tissues. Tyramine inhibits the GABAergic VD motor-neurons through activation of the Gαo coupled receptor SER-2 [29]. The inhibition of GABA release onto ventral body wall muscle facilitates the deep ventral contraction during the omega turn. FLP-18 on the other hand activates NPR-5 in the neck- and body wall-muscles resulting in increased calcium levels and enhanced head and body bending. Thus, co-transmission of FLP-18 and tyramine exert excitatory and inhibitory effects in different cells resulting in functional synergism that enhances omega bending (Fig 8A and 8B). In contrast to the complementary function of tyramine and FLP-18 on body bending, we observe convergent but antagonistic effects of these neuromodulators on exploratory head oscillations. During the reversal phase of the escape response, wild-type C. elegans suppress head oscillations to increase its chances to escape encounters with hyphal nooses of predatory fungi [27]. Tyramine release from the RIM mediates the suppression of head oscillations through the activation of a tyramine-gated chloride channel, LGC-55, in neck muscles and cholinergic motor neurons that synapse onto neck muscles [28]. Animals that overexpress FLP-18 fail to suppress head oscillations during reversals, but this defect is rescued by loss of npr-5. The simplest explanation is that in FLP-18 overexpressing animals, the tyramine induced hyperpolarization of neck muscles is no longer sufficient to overcome the excess of FLP-18 induced depolarization. In the behavioral sequence of the escape response, head oscillations are reinitiated during the forward run that follows the omega turn. The tyraminergic activation of a fast-acting ionotropic LGC-55 receptor and FLP-18 activation of the slow-acting metabotropic NPR-5 receptor may contribute to coordinate the timing of suppression and re-initiation of head oscillations.

The use of genetically tractable model organisms with simple nervous systems like C. elegans allows systematic interrogation of the mechanisms underlying co-transmitter modulation of behavior. Our work has shown examples of convergent/antagonistic as well as divergent/complementary actions of co-transmitters released from a single neuron pair. Using a similar genetic and behavioral approach, other functional properties of co-transmission have been elucidated in C. elegans. Co-transmission of serotonin and the neuropeptide NLP-3 coordinate the activity of the C. elegans egg-laying circuit [74]. Foraging behavior and olfactory adaptation are shaped by convergent / antagonistic co-transmission of glutamate and NLP-1 from the AWC sensory neurons to dampen olfactory responses [75].

The complexity of mammalian system makes it more difficult to dissect the in vivo consequences of neuropeptide and co-transmission. Nevertheless, there are intriguing similarities in mammals where neuropeptide Y (NPY) is co-released with noradrenaline (NA) in response to stress [6,7,15,16,76,77]. In mammals, co-transmission of NA and NPY in the mammalian sympathetic nervous system has both complementary and antagonistic actions. For example, both NA and NPY produce a pressor response through contraction in vascular smooth muscle [10,12,16], while NPY and NA have opposing inotropic and chronotropic effects on cardiac muscle [11,13,14,78]. The similarities between vertebrate NA/NPY and C. elegans tyramine/FLP-18 signaling indicate that co-transmission monoamines and neuropeptides is a central feature of the signaling pathways that underlie arousal in response to stress. In the presence of danger, heightened arousal can prepare an animal to respond more effectively to a threat and increase the chance of survival. The stereotyped C. elegans escape response allows us to elucidate how co-transmission from a single neuron can shape circuit activity on different time scales to orchestrate arousal and physiology in response to stress.

Materials and methods

Molecular biology and transgenics

Standard molecular biology methods were used. A list of strains used is this manuscript is included as Table 1. Most transgenic strains were made through microinjection of plasmid DNA into lin-15(n765ts). A lin-15 rescuing plasmid (PL15EK) was used as a co-injection marker (80 ng/μl) and transgenics were identified based on rescue of the lin-15 multivulva phenotype. FLP-18 transgenic strains were created by amplifying a 5.9kb sequence of genomic DNA beginning 3.3kb upstream of the open reading frame and containing the flp-18 coding region as well as the 3’ UTR. The sequence was amplified using the forward primer 5’-GTGATGTAGGTAGCGCGGAAC-3’ and 5’-TTCATGATCCCAGATTCAATTAATC-3’ reverse primer. This amplicon was ligated into a plasmid containing an SL2 linked mCherry transcriptional reporter to visualize expression. This plasmid was injected along with pL15EK and transgenics were identified based on lin-15 rescue. The extrachromosomal array was stably integrated into the genome using X-ray irradiation and were backcrossed to wild type N2 animals 4 times. NPR-5 transgenics were created using Gibson Assembly (Gibson Assembly Master Mix (E2611), New England BioLabs inc., [79]) to insert the npr-5 genomic locus into a pSP72 plasmid backbone. The insert consisted of a 7.7kb sequence of genomic DNA beginning 3kb upstream of the npr-5 open reading frame and including the npr-5 coding sequence and 3’ UTR. The sequence was amplified using 5’-cagatctgatatcatcgatGGCCCCGTGATTCTTGTCA-3’ as a forward primer and 5’-atccccgggtaccgagctcgaatTCTTGCTCGGTGTGCATTTTC-3’ as a reverse primer. The lowercase letters indicate the homology arms that anneal to pSP72 sequence, and the uppercase letters anneal to the npr-5 genomic locus for amplification. pSP72 was linearized for insertion using EcoRI. The resulting plasmid was injected along with pL15EK and transgenics were identified based on lin-15 rescue.

Table 1. Strain List.

A list of C. elegans strains used in this manuscript.

N2 Wild Type
CX4148 npr-1(ky13)
QW940 npr-4(tm1782) 4x backcrossed from FX1782
QW953 npr-5(ok1583) 4x backcrossed from RB1393
QW1223 flp-18(tm2179); zfex528[Pcex-1::FLP-18::SL2::mCherry] (injected at 100ng/μl)
QW1379 flp-18(gk3063) 4x backcrossed from VC2016
QW1526 lin-15(n765ts), zfex713[Pnpr-5::NPR-5 unc-122::RFP +PL15EK] (injected at 200ng/μl)
QW1646 lin-15(n765ts); zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6 +PL15EK] (injected at 100ng/μl)
QW1655 [FLP-18(+++)] lin-15(n765ts); zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK] X. (injected at 200ng/μl) 4x backcrossed.
QW1675 npr-4(tm1782); zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK] X.
QW1677 zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6]; zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK] X.
QW1680 [FLP-18(+)] flp-18(gk3063); zfex821[pflp-18::FLP-18, +unc-122::GFP] (injected at 20ng/μl)
QW1714 lin-15(n765ts), zfex837[pflp-18::FLP-18::Venus +PL15EK] (injected at 200ng/μl)
QW1754 lin-15(n765ts); zfex845[Pmyo-3::NPR-5::SL2::mCherry +PL15EK] (injected at 200ng/μl)
QW1770 lin-15(n765ts); zfex852[Pnpr-5::NPR-5::GFP +PL15EK] (injected at 200ng/μl)
QW1784 npr-5(ok1583); zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6]; zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK]
QW1802 flp-18(gk3063); zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6]
QW1818 npr-5(ok1583); zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK]
QW1819 npr-5(ok1583); zfex813[pmyo-3::NLSwcherry::SL2::GCamp6]
QW1827 egl-30(ad805); zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6]; zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK]
QW1855 egl-30(ad805); zfex813[Pmyo-3::NLSwCherry::SL2::GCaMP6]
QW2169 npr-1(ky13); zfis149[Pflp-18(3kb)::mCherry::SL2::FLP-18 +PL15EK]

Behavioral experiments

All behavioral experiments were carried out using young adult animals which had been staged as L4s the previous day. Behavioral experiments were performed on medium (60mm) thin-lawn NGM plates where a single drop of OP50 (~30μl) was spread across the plate and allowed to grow at room temperature overnight. Thin lawn plates older than 24hrs were discarded. Prior to behavioral experiments, animals were transferred from standard plates to thin lawn plates and allowed to acclimate for at least 5 minutes. All experiments were conducted with 20 worms to a plate unless otherwise stated and were run in parallel with wild type controls across at least 3 days.

Worm tracking

Quantification of locomotion was performed using one of two different worm tracking systems. For quantification of foraging speed (Fig 2C), the Worm Tracker 2.0 system was used (Eviatar Yemini and Tadas Jucikas, https://www.mrc-lmb.cam.ac.uk/wormtracker, [80]) and “absolute foraging speed” was reported. A single animal on a thin lawn plate was tracked for 5 minutes at 30fps using a USB digital microscope (DinoLite Pro AM413T, Dino-Lite US) on a motorized stage (Zaber TNA08A50 linear actuator and Zaber TSB60-M motorized stage, Zaber Technologies Inc.).

Quantification of velocity, body curvature and reversal frequency were measured using the Multi-Worm Tracker (Rex Kerr, https://sourceforge.net/projects/mwt/). When tracking experiments included a tap stimulus, the stimulus was delivered by a tubular push solenoid (Saia-Burgess/Ledex #195205–127) controlled by the Multi-Worm Tracker software. The tap stimulus consisted of a train of 20 taps with an inter tap interval of 10 milliseconds. Tap stimuli were always delivered after 5 minutes of tracking had elapsed.

Experiments were analyzed using custom MATLAB (The MathWorks, Inc.) scripts to interface with the Multi-Worm Tracker feature extraction software Choreography. Analysis was limited to objects that had been tracked for a minimum of 20 seconds and had moved a minimum of 5 body lengths. All experiments were conducted on thin lawn plates with 20 animals on each plate.

Body curvature

For comparisons of basal versus tap stimulated curvature animals were tracked using the Multi-Worm Tracker. The body curvature of the population was averaged over 5 seconds either just prior to the tap stimulus for basal curvature or just after the tap stimulus for stimulated curvature.

Reversal frequency

20 animals were tracked while freely moving on a thin lawn plate with the Multi-Worm Tracker. The total number of reversals made by the population in a 3-minute window was extracted using the Multisensed plugin for Choreography (Rex Kerr) and divided by the average number of worms tracked during that time to get the number of reversals per worm in 3 minutes. For simplicity this value was divided by 3 and plotted as number of reversals per worm per minute.

Touch assays

Experiments quantifying omega turning, suppression of head oscillations and ventral turn head angle were conducted by gently touching an animal just posterior to the pharynx with a fine paint brush bristle taped to a glass pipette as previously described [47]. Animals were transferred to a thin lawn plate and allowed to acclimate for at least 5 minutes. 20 animals were assayed in each experiment and the population average was reported for each behavior. Animals were touched a single time and animals that failed to reverse were ignored. Animals that moved their head from side to side during a reversal were scored as defective in the suppression of head oscillations.

Omega turns

Omega turns were defined as any turn which results in a reorientation greater than 90° from their initial forward bearing before the reversal. Turns that were greater than 90° where the animal failed to touch its body with its head were considered open omega turns. Percent omega turns for a given experiment was calculated as the number of open plus the number of closed turns divided by the total number of animals that reversed. The percentage of open omegas was calculated as the number of open omega turns divided by the total number of omega turns (open + closed) in that experiment.

Ventral turn angle

To calculate the angle of the head during the initiation of a ventral turn animals were touched with an eyelash while video was being recorded through a dissecting microscope (SZ6TR1 Olympus) with a digital camera (AVT Pike F421-b, Allied Vision Technologies) using Fire-I image acquisition software (Unibrain inc.). Videos of animals that made omega turns were loaded into ImageJ / Fiji [81] and the first frame of forward movement following the touch initiated reversal was identified. To calculate the head deflection angle two lines were drawn, one running from the tip of the nose to the beginning of the intestine and the second running from the beginning of the intestine to a point on the midline 1 pharynx length further posterior. The angle between these two lines was measured using the angle tool in Fiji.

Confocal imaging

Animals were immobilized with 60mM sodium azide and placed on a 2% agarose pad under a coverslip. Images were acquired using a Zeiss LSM700 confocal microscope (Carl Zeiss AG)

Venus quantification

A population of animals expressing the Pflp-18::FLP-18::Venus transgene were subjected to a plate tap every 2 minutes for up to 2 hours. Individuals were removed at 0, 1 and 2 hours and immediately mounted and anesthetized as described above. Z-stacks were acquired with a confocal microscope (LSM 700, Carl Zeiss Microscopy GmbH) using a 40x objective (C-Apochromat 40x/1.20 W Korr, Carl Zeiss Microscopy GmbH). Images were loaded into ImageJ and the soma of the RIM and AVA were identified from their anatomical location. A circular region of interest (ROI) with a diameter of 13.5μm was placed around the soma or coelomocyte to measure the mean grey value of each neuron. An additional measurement was taken adjacent to the soma to quantify background fluorescence; this value was subtracted from the gray values of the RIM, AVA, and coelomocyte in that animal. The values obtained for each condition were normalized to the average intensity of the relevant neuron or coelomocyte in the control condition.

Calcium imaging

Young adult animals expressing a Pmyo-3::GCaMP6::SL2::mCherry transgene were placed into a drop of M9 buffer on a 2% agarose pad atop a microscope slide and a coverslip was gently placed onto the pad. Animals were able to move freely under the coverslip and were imaged on an inverted fluorescent microscope (Axio Observer A.1, Carl Zeiss Microscopy GmbH) using a Hammamatsu ORCA-Flash4.0 camera within 10 minutes of mounting. Images were analyzed using ImageJ software by drawing a 1075μm x 630μm rectangular ROI which could be rotated or translated to fit the position of an animal and the mean gray value was measured. The same ROI was placed in a position containing no animals to measure the mean grey value of the background which was then subtracted from the grey value of the ROI containing the animal. Wild type animals expressing the Pmyo-3::GCaMP6::SL2::mCherry transgene were imaged in parallel with mutants and the average background-subtracted grey value of the wild type animals for that day was used to normalize the values obtained from imaging the mutants. mCherry imaging was performed in a similar manner using the same rectangular ROI and the raw pixel values were quantified.

Supporting information

S1 Fig. Escape behavior in tdc-1;flp-18 double mutants.

(A and B) Behavioral schematic (top) and velocity traces (bottom) of animals executing the escape response. (A) In wild type animals, forward run velocity remains elevated for approximately 3 minutes after the escape response. Dotted line marks pre-stimulus baseline. (B) Comparison of tdc-1;flp-18 double mutants to the velocity traces presented in Fig 1B. (A-B) Negative velocity indicates backward locomotion. Solid line in trace represents mean velocity, shaded area indicates standard error of the mean. (C-F) Quantification of escape behavior in flp-18, tdc-1, and tdc-1;flp-18 mutant animals. See Fig 3 for details. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.005 = **, P<0.0005 = ***, P<0.0001 = ****). Sample size: (A) n = 14 independent trials with 20 worms recorded during each trial. (B) n = # of animals. Wild type, flp-18, and tdc-1 values are reported in Fig 1. tdc-1;flp-18 (n = 204). (C-E), n = # of experiments, 20 worms per experiment. Wild type (n = 12), flp-18 (n = 11), tdc-1 (n = 12), tdc-1;flp-18 (n = 11). (F) n = # of animals. Wild type (n = 88), flp-18 (n = 58), tdc-1 (n = 60), tdc-1;flp-18 (n = 60).

(TIF)

S2 Fig. Expression pattern and behavioral analysis of Pcex-1::FLP-18::SL2::mCherry.

(A) Confocal z-projection of zfEx528[Pcex-1::FLP-18::SL2::mCherry showing detail of head neurons. Cell bodies are labeled, neurons were identified based on anatomical position. (B-D) Analysis of FLP-18 overexpression from endogenous (Pflp-18) and cell specific (Pcex-1) promotors. Spontaneous reversal frequency (B), mean body curvature averaged over 5 seconds prior to (C), or immediately following (D), a tap stimulus. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.0001 = ****). Sample size: (B-D) n = # of experiments, 20 animals per experiment. Wild type (n = 16), Pflp-18::FLP-18(+++) (n = 4), Pcex-1::FLP-18(+++) (n = 6).

(TIF)

S3 Fig. Animals overexpressing FLP-18 fail to suppress head oscillations during escape.

Minimum intensity projections from video recordings of wild type (A) and FLP-18 overexpressing animals (B) after anterior touch. “start” indicates location of head when the animal was touched and initiated a reversal. The omega (Ω) symbol indicates the point where an omega turn was initiated, and the animal switched from reversal to forward motion. “end" indicates the position of the head at the end of the video. The head of the wild-type animal remains relaxed and follows the body during the reversal (A). The FLP-18(+++) overexpressing animal continues head oscillations during the reversal which are visible as the tip of the nose projecting out from the sides of the body and are indicated with red arrows (B). Scale bar = 100μm.

(TIF)

S4 Fig. Characterization of reversal behavior and body curvature in FLP-18 receptor mutants.

(A and B) Quantification of mean body curvature averaged over 5 seconds prior to a tap stimulus (A) or immediately following a strong tap stimulus (B). (C and D) npr-5 but not npr-1 mutation suppresses high spontaneous reversal frequency in low oxygen conditions. Quantification of spontaneous reversal frequency in ambient oxygen (C) or in low oxygen conditions (D). Mean number of spontaneous reversals per minute per worm averaged over 3 minutes as in Fig 5H. Ambient oxygen experiments (C) were conducted with a standard lid-covered plate in room air. Low-oxygen experiments (D) were conducted on a plate that had nitrogen gas injected into it with a 5ml syringe prior to placing a lid. After lid placement, both conditions were allowed to acclimate for 5 minutes prior to recording. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.005 = **, P<0.0001 = ****). Sample sizes (# of experiments, 20 animals per experiment): (A-B) wild type (n = 22), npr-1 (n = 14), npr-4 (n = 12), npr-5 (n = 13). (C) wild type (n = 26), flp-18 (n = 28), npr-1 (n = 14), npr-4 (n = 23), npr-5 (n = 17). (D) wild type (n = 12), FLP-18(+++) (n = 12), npr-1; FLP-18(+++) (n = 15), npr-5; FLP-18(+++) (n = 13).

(TIF)

S5 Fig. Muscle::mCherry levels are unaffected by mutations in FLP-18 signaling.

Quantification of mCherry fluorescence in animals expressing the transgene zfEx813[Pmyo-3::NLSwCherry::SL2::GCaMP6] (muscle::GCaMP) in the genetic backgrounds analyzed in Fig 7B. Because the FLP-18 overexpression line (zfIs149[Pflp-18(3kb)::mCherry::SL2::FLP-18]) carries an mCherry transcriptional reporter, mutant lines are compared to their respective control background, muscle::GCaMP (A) or muscle::GCaMP; FLP-18(+++) (B). (C) Fluorescent micrograph showing mCherry, GCaMP and merged signals of a animals expressing zfIs149 alone (bottom, FLP-18(+++)) or in combination with zfEx813 (top, muscle::GCaMP; FLP-18(+++)). Scale bar = 200 μm. Graphs represent mean ± SEM, significance was calculated using ANOVA with Dunnett’s multiple comparison correction (P>0.05 = ns). Sample sizes (# animals): (A) muscle::GCaMP (n = 46), flp-18 (n = 30), npr-5 (n = 23), egl-30 (n = 15). (B) FLP-18(+++) (n = 39), npr-5; FLP-18(+++) (n = 21), egl-30; FLP-18(+++) (n = 30).

(TIF)

S1 Data. Raw data used to generate all graphs in the manuscript.

The compressed folder contains 11 excel files each corresponding to a figure which is specified in the filename. Excel files are broken down into multiple sheets, each containing the data for an individual panel of a figure.

(ZIP)

S1 Video. Locomotion of Pflp-18_FLP-18(+++): overexpression of FLP-18 driven by the endogenous promotor results in uncoordinated locomotion, deep body bends and increased reversals.

(MP4)

S2 Video. Locomotion of Pcex-1_FLP-18(+++): overexpression of FLP-18 from the cex-1 drives expression in the RIM, AVA, and AVD and results in uncoordinated locomotion, deep body bends and increased reversals, similar to overexpression from the endogenous promoter.

(MP4)

S3 Video. Touch response in wild type.

The escape response to anterior touch in wild type animals consists of a reversal during which head movements are suppressed followed by an omega turn and resumption of head movements and forward locomotion in the opposite direction. An eyelash is used to gently touch the animal behind the head to trigger the escape response.

(MP4)

S4 Video. Touch response in FLP-18(+++).

The escape response in animals overexpressing FLP-18 results in deeper body bends and a failure to suppress exploratory head movements while reversing. An eyelash is used to gently touch the animal behind the head to trigger the escape response.

(MP4)

Acknowledgments

Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank Mario de Bono for strains and Rex Kerr for the multi-worm tracker software, Will Joyce for worm injections and Michael Francis for critically reading the manuscript, Daniel Witvliet and Mei Zhen for sharing RIM electron microscopy images.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by NIH grant GM140480 and NS107475 from the National Institutes of Health (MJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Nusbaum MP, Blitz DM, Marder E. Functional consequences of neuropeptide and small-molecule co-transmission. Nat Rev Neurosci. 2017;18(7):389–403. doi: 10.1038/nrn.2017.56 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Svensson E, Apergis-Schoute J, Burnstock G, Nusbaum MP, Parker D, Schiöth HB. General principles of neuronal co-transmission: Insights from multiple model systems. Front Neural Circuits. 2019;12(January):1–28. doi: 10.3389/fncir.2018.00117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cannon WB. Bodily Changes in Pain, Hunger, Fear and Rage; An Account of Recent Researches into the Function of Emotional Excitement. NEW YORK AND LONDON D. APPLETON AND COMPANY; 1915. [Google Scholar]
  • 4.Horn JP, Swanson LW. Principles of Neural Science. 5th ed. Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ, editors. New York: McGraw Hill; 2013. doi: 10.1126/science.1239052 [DOI] [Google Scholar]
  • 5.Li HY, Sawchenko PE. Hypothalamic effector neurons and extended circuitries activated in “neurogenic” stress: A comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol. 1998;393(2):244–66. [PubMed] [Google Scholar]
  • 6.Lundberg JM, Terenius L, Hökfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett. 1983;42(2):167–72. doi: 10.1016/0304-3940(83)90401-9 [DOI] [PubMed] [Google Scholar]
  • 7.Everitt BJ, Hökfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. 1984;11(2). doi: 10.1016/0306-4522(84)90036-8 [DOI] [PubMed] [Google Scholar]
  • 8.Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience. 1989;28(2):475–86. doi: 10.1016/0306-4522(89)90193-0 [DOI] [PubMed] [Google Scholar]
  • 9.Westfall TC, Martin J, Chen X, Ciarleglio A, Carpentier S, Henderson K, et al. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse. 1988;2(3):299–307. doi: 10.1002/syn.890020320 [DOI] [PubMed] [Google Scholar]
  • 10.Wahlestedt C, Hakanson R, Vaz CA, Zukowska-Grojec Z. Norepinephrine and neuropeptide Y: Vasoconstrictor cooperation in vivo and in vitro. Am J Physiol—Regul Integr Comp Physiol. 1990;258(3 27–3):736–42. doi: 10.1152/ajpregu.1990.258.3.R736 [DOI] [PubMed] [Google Scholar]
  • 11.Allen AR, Kelso EJ, Bell D, Zhao YY, Dickson P, McDermott BJ. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy. J Pharmacol Exp Ther. 2006;319(3):1286–96. doi: 10.1124/jpet.106.110445 [DOI] [PubMed] [Google Scholar]
  • 12.Wahlestedt C, Edvinsson L, Ekblad E, Hakanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: Mode of action. J Pharmacol Exp Ther. 1985;234(3):735–41. [PubMed] [Google Scholar]
  • 13.Zukowska-Grojec Z, Marks ES, Haass M. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am J Physiol—Hear Circ Physiol. 1987;253(5). doi: 10.1152/ajpheart.1987.253.5.H1234 [DOI] [PubMed] [Google Scholar]
  • 14.Oki Y, Teraoka H, Kitazawa T. Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor. Auton Autacoid Pharmacol. 2017;37(2):23–8. doi: 10.1111/aap.12055 [DOI] [PubMed] [Google Scholar]
  • 15.Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982;116(4):477–80. doi: 10.1111/j.1748-1716.1982.tb07171.x [DOI] [PubMed] [Google Scholar]
  • 16.Zukowska-Grojec Z, Vaz AC. Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse. 1988;2(3):293–8. doi: 10.1002/syn.890020319 [DOI] [PubMed] [Google Scholar]
  • 17.Toth PT, Bindokas VP, Bleakman D, Colmers WF, Miller RJ. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature. 1993;364(6438):635–9. doi: 10.1038/364635a0 [DOI] [PubMed] [Google Scholar]
  • 18.McDermott BJ, Millar BC, Dolan FM, Bell D, Balasubramaniam A. Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur J Pharmacol. 1997;336(2–3):257–65. doi: 10.1016/s0014-2999(97)01258-2 [DOI] [PubMed] [Google Scholar]
  • 19.Balasubramaniam A, Grupp I, Matlib MA, Benza R, Jackson RL, Fischer JE, et al. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria. Regul Pept. 1988;21(3–4):289–99. doi: 10.1016/0167-0115(88)90012-2 [DOI] [PubMed] [Google Scholar]
  • 20.White JG, Southgate E, Thomson JN, Brenner S. The Structure of the Nervous System of the Nematode Caenorhabditis elegans. Philos Trans R Soc B Biol Sci. 1986;314(1165):1–340. doi: 10.1098/rstb.1986.0056 [DOI] [PubMed] [Google Scholar]
  • 21.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. doi: 10.1093/genetics/77.1.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Li C, Nelson LS, Kim K, Nathoo A, Hart AC. Neuropeptide Gene Families in the Nematode Caenorhabditis elegans. Ann N Y Acad Sci. 1999;897(1):239–252. doi: 10.1111/j.1749-6632.1999.tb07895.x [DOI] [PubMed] [Google Scholar]
  • 23.Li C, Kim K. Family of FLP Peptides in Caenorhabditis elegans and Related Nematodes. Front Endocrinol (Lausanne). 2014. Jan;5(October):150. doi: 10.3389/fendo.2014.00150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bauknecht P, Jékely G. Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians. BMC Biol. 2017;15(1):1–12. doi: 10.1186/s12915-016-0343-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.De Rosa MJ, Veuthey T, Florman J, Grant J, Blanco MG, Andersen N, et al. The flight response impairs cytoprotective mechanisms by activating the insulin pathway. Vol. 573, Nature. Springer US; 2019. p. 135–8. doi: 10.1038/s41586-019-1524-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alkema MJ, Hunter-Ensor M, Ringstad N, Horvitz HR. Tyramine functions independently of octopamine in the Caenorhabditis elegans nervous system. Neuron. 2005;46(2):247–60. doi: 10.1016/j.neuron.2005.02.024 [DOI] [PubMed] [Google Scholar]
  • 27.Maguire SM, Clark CM, Nunnari J, Pirri JK, Alkema MJ. The C. elegans touch response facilitates escape from predacious fungi. Curr Biol. 2011. Aug 9;21(15):1326–30. doi: 10.1016/j.cub.2011.06.063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pirri JK, McPherson AD, Donnelly JL, Francis MM, Alkema MJ. A Tyramine-Gated Chloride Channel Coordinates Distinct Motor Programs of a Caenorhabditis elegans Escape Response. Neuron. 2009;62(4):526–38. doi: 10.1016/j.neuron.2009.04.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Donnelly JL, Clark CM, Leifer AM, Pirri JK, Haburcak M, Francis MM, et al. Monoaminergic orchestration of motor programs in a complex C. elegans behavior. PLoS Biol. 2013. Apr;11(4):e1001529. doi: 10.1371/journal.pbio.1001529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ringstad N, Abe N, Horvitz HR. Ligand-Gated Chloride Channels Are Receptors for Biogenic Amines in C. elegans. Science (80-). 2009. Jul 3;325(5936):96–100. doi: 10.1126/science.1169243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pirri JK, Rayes D, Alkema MJ. A Change in the Ion Selectivity of Ligand-Gated Ion Channels Provides a Mechanism to Switch Behavior. PLoS Biol. 2015;13(9):1–20. doi: 10.1371/journal.pbio.1002238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rogers C, Reale V, Kim K, Chatwin H, Li C, Evans P, et al. Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1. Nat Neurosci. 2003. Nov;6(11):1178–85. doi: 10.1038/nn1140 [DOI] [PubMed] [Google Scholar]
  • 33.Kim K, Li C. Expression and regulation of an FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. J Comp Neurol. 2004;475(4):540–50. doi: 10.1002/cne.20189 [DOI] [PubMed] [Google Scholar]
  • 34.Elphick MR, Mirabeau O. The evolution and variety of RFamide-type neuropeptides: Insights from deuterostomian invertebrates. Front Endocrinol (Lausanne). 2014;5(JUN):1–11. doi: 10.3389/fendo.2014.00093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gershkovich MM, Groß VE, Kaiser A, Prömel S. Pharmacological and functional similarities of the human neuropeptide y system in C. elegans challenges phylogenetic views on the FLP/NPR system. Cell Commun Signal. 2019;17(1):1–15. doi: 10.1186/s12964-018-0315-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Cohen M, Reale V, Olofsson B, Knights A, Evans P, de Bono M. Coordinated regulation of foraging and metabolism in C. elegans by RFamide neuropeptide signaling. Cell Metab. 2009. Apr;9(4):375–85. doi: 10.1016/j.cmet.2009.02.003 [DOI] [PubMed] [Google Scholar]
  • 37.Sanders J, Levine E, Biron D, Nagy S, Tramm N, Iwanir S, et al. Homeostasis in C. elegans sleep is characterized by two behaviorally and genetically distinct mechanisms. Elife. 2014;3:1–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Choi S, Taylor KP, Chatzigeorgiou M, Hu Z, Schafer WR, Kaplan JM. Sensory Neurons Arouse C. elegans Locomotion via Both Glutamate and Neuropeptide Release. PLoS Genet. 2015;11(7):1–20. doi: 10.1371/journal.pgen.1005359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Stawicki TM, Takayanagi-Kiya S, Zhou K, Jin Y. Neuropeptides function in a homeostatic manner to modulate excitation-inhibition imbalance in C. elegans. PLoS Genet. 2013. May;9(5):e1003472. doi: 10.1371/journal.pgen.1003472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Luo J, Xu Z, Tan Z, Zhang Z, Ma L. Neuropeptide receptors npr-1 and npr-2 regulate caenorhabditis elegans avoidance response to the plant stress hormone methyl salicylate. Genetics. 2014;199(2):523–31. doi: 10.1534/genetics.114.172239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bhardwaj A, Thapliyal S, Dahiya Y, Babu K. FLP-18 functions through the G-protein coupled receptors NPR-1 and NPR-4 to modulate reversal length in Caenorhabditis elegans. J Neurosci. 2018;38(20):1955–17. doi: 10.1523/JNEUROSCI.1955-17.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bhardwaj A, Pandey P, Babu K. Control of locomotory behavior of caenorhabditis elegans by the immunoglobulin superfamily protein RIG-3. Genetics. 2020;214(1):135–45. doi: 10.1534/genetics.119.302872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chang YJ, Burton T, Ha L, Huang Z, Olajubelo A, Li C. Modulation of locomotion and reproduction by FLP neuropeptides in the nematode Caenorhabditis elegans. PLoS One. 2015;10(9):1–16. doi: 10.1371/journal.pone.0135164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kubiak TM, Larsen MJ, Bowman JW, Geary TG, Lowery DE. FMRFamide-like peptides encoded on the flp-18 precursor gene activate two isoforms of the orphan Caenorhabditis elegans G-protein-coupled receptor Y58G8A.4 heterologously expressed in mammalian cells. Biopolymers. 2008. Jan;90(3):339–48. doi: 10.1002/bip.20850 [DOI] [PubMed] [Google Scholar]
  • 45.Swierczek N a, Giles AC, Rankin CH, Kerr R a. High-throughput behavioral analysis in C. elegans. Nat Methods. 2011. Jul;8(7):592–8. doi: 10.1038/nmeth.1625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chew YL, Tanizawa Y, Cho Y, Zhao B, Yu AJ, Ardiel EL, et al. An Afferent Neuropeptide System Transmits Mechanosensory Signals Triggering Sensitization and Arousal in C. elegans. Neuron. 2018;99(6):1233–1246.e6. doi: 10.1016/j.neuron.2018.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Chalfie M, Sulston J. Developmental genetics of the mechanosensory neurons of Caenorhabditis elegans. Dev Biol. 1981;82(2):358–70. doi: 10.1016/0012-1606(81)90459-0 [DOI] [PubMed] [Google Scholar]
  • 48.Wicks SR, Rankin CH. Integration of mechanosensory stimuli in Caenorhabditis elegans. J Neurosci. 1995;15(3 Pt 2):2434–44. doi: 10.1523/JNEUROSCI.15-03-02434.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Shipley FB, Clark CM, Alkema MJ, Leifer AM. Simultaneous optogenetic manipulation and calcium imaging in freely moving C. elegans. Front Neural Circuits. 2014. Mar 24;8(March):1–8. doi: 10.3389/fncir.2014.00028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Starich TA, Xu J, Skerrett IM, Nicholson BJ, Shaw JE. Interactions between innexins UNC-7 and UNC-9 mediate electrical synapse specificity in the Caenorhabditis elegans locomotory nervous system. Neural Dev. 2009;4(1):1–28. doi: 10.1186/1749-8104-4-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kawano T, Po MD, Gao S, Leung G, Ryu WS, Zhen M. An imbalancing act: gap junctions reduce the backward motor circuit activity to bias C. elegans for forward locomotion. Neuron. 2011. Nov 17;72(4):572–86. doi: 10.1016/j.neuron.2011.09.005 [DOI] [PubMed] [Google Scholar]
  • 52.Sieburth D, Madison JM, Kaplan JM. PKC-1 regulates secretion of neuropeptides. Nat Neurosci. 2007;10(1):49–57. doi: 10.1038/nn1810 [DOI] [PubMed] [Google Scholar]
  • 53.Hoover CM, Edwards SL, Yu S, Kittelmann M, Richmond JE, Eimer S, et al. A novel CaM kinase II pathway controls the location of neuropeptide release from Caenorhabditis elegans motor neurons. Genetics. 2014. Mar;196(3):745–65. doi: 10.1534/genetics.113.158568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. 2002;20(1):87–90. doi: 10.1038/nbt0102-87 [DOI] [PubMed] [Google Scholar]
  • 55.Fares H, Greenwald I. Genetic analysis of endocytosis in caenorhabditis elegans: Coelomocyte uptake defective mutants. Genetics. 2001;159(1):133–45. doi: 10.1093/genetics/159.1.133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Busch KE, Laurent P, Soltesz Z, Murphy RJ, Faivre O, Hedwig B, et al. Tonic signaling from O 2 sensors sets neural circuit activity and behavioral state. Nat Neurosci. 2012;15(4):581–91. doi: 10.1038/nn.3061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Maryon EB, Saari B, Anderson P. Muscle-specific functions of ryanodine receptor channels in Caenorhabditis elegans. J Cell Sci. 1998. Oct;111 (Pt 1:2885–95. doi: 10.1242/jcs.111.19.2885 [DOI] [PubMed] [Google Scholar]
  • 58.Jospin M, Jacquemond V, Mariol M-C, Ségalat L, Allard B. The L-type voltage-dependent Ca2+ channel EGL-19 controls body wall muscle function in Caenorhabditis elegans. J Cell Biol. 2002. Oct 28;159(2):337–48. doi: 10.1083/jcb.200203055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Streb H, Irvine RF, Berridge MJ, Schulz I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature. 1983;306(5938):67–9. doi: 10.1038/306067a0 [DOI] [PubMed] [Google Scholar]
  • 60.Garcia LR, Mehta P, Sternberg PW. Regulation of distinct muscle behaviors controls the C. elegans male’s copulatory spicules during mating. Cell. 2001;107(6):777–88. doi: 10.1016/s0092-8674(01)00600-6 [DOI] [PubMed] [Google Scholar]
  • 61.Brundage L, Avery L, Katz A, Kim UJ, Mendel JE, Sternberg PW, et al. Mutations in a C. elegans Gqα gene disrupt movement, egg laying, and viability. Neuron. 1996;16(5):999–1009. doi: 10.1016/s0896-6273(00)80123-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Miller K, Emerson M, Rand J. G o α and Diacylglycerol Kinase Negatively Regulate the G q α Pathway in C. elegans. Neuron. 1999;24:323–33. doi: 10.1016/s0896-6273(00)80847-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bastiani CA, Gharib S, Simon MI, Sternberg PW. Caenorhabditis elegans Gαq Regulates Egg-Laying Behavior via a PLCβ-Independent and Serotonin-Dependent Signaling Pathway and Likely Functions Both in the Nervous System and in Muscle. Genetics. 2003;165(4):1805–22. doi: 10.1093/genetics/165.4.1805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Gollasch M, Haller H, Schultz G, Hescheler J. Thyrotropin-releasing hormone induces opposite effects on Ca2+ channel currents in pituitary cells by two pathways. Proc Natl Acad Sci U S A. 1991;88(22):10262–6. doi: 10.1073/pnas.88.22.10262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Xu S, Chisholm AD. A Gαq-Ca2+ signaling pathway promotes actin-mediated epidermal wound closure in C. elegans. Curr Biol. 2011;21(23):1960–7. doi: 10.1016/j.cub.2011.10.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Choi S, Chatzigeorgiou M, Taylor KP, Schafer WR, Kaplan JM. Analysis of NPR-1 reveals a circuit mechanism for behavioral quiescence in C.elegans. Neuron. 2013;78(5):869–80. doi: 10.1016/j.neuron.2013.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chen D, Taylor KP, Hall Q, Kaplan JM. The Neuropeptides FLP-2 and PDF-1 act in Concert to Arouse Caenorhabditis elegans Locomotion. Genetics. 2016;204(November):genetics.116.192898. doi: 10.1534/genetics.116.192898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Serrano-Saiz E, Poole RJ, Felton T, Zhang F, De La Cruz ED, Hobert O. Modular Control of Glutamatergic Neuronal Identity in C. elegans by Distinct Homeodomain Proteins. Cell. 2013. Oct;155(3):659–73. doi: 10.1016/j.cell.2013.09.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Sordillo A, Bargmann CI. Behavioral control by depolarized and hyperpolarized states of an integrating neuron. BioRxiv. 2021;1–54. doi: 10.7554/eLife.67723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Taylor SR, Santpere G, Weinreb A, Barrett A, Reilly MB, Xu C, et al. Molecular topography of an entire nervous system. Cell. 2021;184(16):4329–4347.e23. doi: 10.1016/j.cell.2021.06.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Witvliet D, Mulcahy B, Mitchell JK, Meirovitch Y, Berger DR, Wu Y, et al. Connectomes across development reveal principles of brain maturation. Nature. 2021;596(May 2020). doi: 10.1038/s41586-021-03778-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol. 1994;127(5):1419–33. doi: 10.1083/jcb.127.5.1419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Hokfelt T, Elfvin LG, Elde R. Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. Proc Natl Acad Sci U S A. 1977;74(8):3587–91. doi: 10.1073/pnas.74.8.3587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Brewer JC, Olson AC, Collins KM, Koelle MR. Serotonin and neuropeptides are both released by the HSN command neuron to initiate C. elegans egg laying. PLoS Genet. 2019;15(1):1–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Chalasani SH, Kato S, Albrecht DR, Nakagawa T, Abbott LF, Bargmann CI. Neuropeptide feedback modifies odor-evoked dynamics in Caenorhabditis elegans olfactory neurons. Nat Neurosci. 2010. May;13(5):615–21. doi: 10.1038/nn.2526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Lundberg JM, Martinsson A, Hemsén A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 1985;133(1):30–6. doi: 10.1016/0006-291x(85)91837-6 [DOI] [PubMed] [Google Scholar]
  • 77.Zukowska-Grojec Z, Konarska M, McCarty R. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci. 1988;42(17):1615–24. doi: 10.1016/0024-3205(88)90440-7 [DOI] [PubMed] [Google Scholar]
  • 78.Michael Piper H, Cherie Millar B, McDermott BJ. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte. Naunyn Schmiedebergs Arch Pharmacol. 1989;340(3):333–7. doi: 10.1007/BF00168519 [DOI] [PubMed] [Google Scholar]
  • 79.Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–5. doi: 10.1038/nmeth.1318 [DOI] [PubMed] [Google Scholar]
  • 80.Yemini Eviatar, Jucikas Tadas, Grundy Laura J., André E.X. Brown and WRS. A database of C. elegans behavioral phenotypes Eviatar. Nat Methods. 2013;10(9):877–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Kaveh Ashrafi

16 Nov 2021

Dear Dr %Alkema%,

Thank you very much for submitting your Research Article entitled 'Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response.' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.  We believe that most of the concerns of each of the three reviewers can addressed through textual revisions.  However, as you can see in their detailed comments, the reviewers have asked for the inclusion of several additional experiments that are necessary for clear interpretation of the results. 

We note that in several specific instances the reviewers have suggested revisions or additions that will strengthen the manuscript, however, we do not believe these additions, while welcomed, are essential for publication of the manuscript as long as the limitations of the work are clearly discussed.  Specifically, we would welcome analysis of "gcy-13::FLP-18 to specifically assess the role of RIM-released FLP-18" (comment of Reviewer #2), and inclusion of "calcium concentrations in body wall muscles that oppose each other in the sinusoidal wave" (comment of Reviewer #3 in relation to Figure 7a).  As noted, inclusion of these data will not be essential for publication but we agree with the reviewers that they would strengthen the manuscript..

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Kaveh Ashrafi

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The work of Floorman and Alkema dissects the functional contributions of co-transmission to the behavioural and circuit modules underlying a scape response in C. elegans. The Alkema lab and others have previously shown that the scape response is elicited through the interneurons RIM and AVA and that RIM co-expresses tyramine and flp-18. Tyramine acts on neck muscles to suppress head oscillations and on gabaergic motor neurons to disinhibit body wall muscle. In this work, they examine the role that the release of the neuropeptide flp-18 from the RIM interneurons upon touch stimulation plays in locomotion to elicit scape. They show that the touch-induced scape response consists of a locomotion sequence which includes a reversal, a change in direction through an omega turn and the resumption of forward locomotion with a sustained increase in velocity. Mutants lacking the peptide flp-18 do not display the increase in velocity during forward movement at the end of the scape response and display fewer and abnormally open omega turns. Through epistasis experiments where they test several receptor mutants for their ability to supress the phenotype of flp-18 overexpression, they identify npr-5 as the receptor mediating the effects of flp-18 on locomotion. Based on rescue experiments of npr-5 comparing the effects of driving expression with endogenous versus heterologous promoters, the authors propose that flp-18 action on muscle regulates velocity, whereas action on neurons regulates reversal frequency. Finally, they show that flp-18 increases intracellular Ca2+ levels in body wall muscle in a npr-5- and egl-30/G� q – dependent manner, an effect which (the authors propose) underlies the increase in velocity mediated by the peptide. Together with their previous findings on the regulation of the scape response by tyramine, this work puts forward a model by which co-release of the monoamine and the peptide act synergistically in body wall muscle and antagonistically in neck muscles. Their action on body wall muscles results in an increase in excitability and worm speed whereas their action in neck muscles regulates the suppression and initiation of head oscillations at different steps of the scape sequence.

Co-transmission of neurotransmitters and neuropeptides is a fundamental property of the nervous system which was identified more than 40 years ago (by Thomas Hökfelt and others). Despite its universality, the impact of co-transmission on circuit function and behaviour is till poorly understood. The work of Floorman and Alkema provide a mechanistic logic for how co-transmission can smoothly orchestrate a behavioural sequence and therefore represent an important advance in the field. Furthermore, the parallel regulation of scape behaviour through the co-release of catecholamines and NPY-related peptides in both worm and mammals suggest that a similar logic may be at play.

Mostly, the experiments are carefully done (the behavioural analysis is particularly powerful) and support the conclusions and model proposed by the authors. I only have a few minor comments.

- A link between flp-18 and the increase in forward speed during scape has been established through analysis of flp-18 mutants in Fig. 1. However, the mechanisms underlying this role of flp-18 have not been elucidated. The authors suggest in the discussion that the increase in body bends and Ca2+ levels/excitability in body wall muscles induced by flp-18 may result in higher velocity, but these more likely underly the quality of omega turns. In addition, flp-18 overexpression does not result in an increase in speed. The authors should make note of this in the discussion to clarify the conclusions.

- In relation with the above, data for npr-5 mutants should be included in Figure 1.

- Figure 1 shows that there is a defect in the length of tap-induced reversals in flp-18 mutants but this is not mentioned in the text. This is particularly relevant in light of the findings the authors refer to in the discussion (line 320): “Recent reports have shown FLP-18 acts through NPR-4 and NPR-5 in the AVA and sensory neurons to control reversal lengths”

- The sentence “FLP-18 neuropeptide since it is the only FRFamide known to be expressed in the tyraminergic RIM neurons and the AVA pre-motor interneurons (Kim and Li, 2004; Rogers et al., 2003)” although correct, it is a bit misleading because both RIM and AVA express other FRFamide peptides. Could the authors modify this sentence to clarify this, and also cite the single cell mRNA profiling paper Taylor et al 2021?

- Line 169 “This indicates that FLP-18 release from the escape circuit neurons AVA and RIM is sufficient to enhance body bending and reversals”. The authors should tone down this conclusion since cex-1 drives (ectopic) expression also in AVD, which is part of the reversal circuit.

- The conclusion that npr-5 acts in muscle to enhance body bending and through neurons to increase reversal frequency could be strengthened by driving expression of npr-5 under the panneuronal rab-3 promoter. Also, in this results section referring to figure 6, the action of npr-5 in neurons comes a bit as a surprise because neuronal expression is neither mentioned in the text nor seen in the reporter images. The authors should indicate earlier that npr-5 is also expressed in neurons.

Typo:

- In line 205 “change as a result of tap treatment (Fig. 3f)”. Should say 4f

Reviewer #2: In this manuscript, Florman and Alkema characterize the role of FLP-18, a neuropeptide that RIM co-releases with tyramine during the escape response. First, they show that mutants lacking flp-18 fail to enhance their speed after tap-induced reversals, even though several other aspects of the escape response (e.g. likelihood of reversing) are intact in these mutants. They then show that overexpression of flp-18 increases body curvature, and foraging (nose movements). Correspondingly, flp-18 mutants display fewer omega turns and more incomplete omegas during the escape response. They then use Venus-tagged FLP-18 to show that the FLP-18 peptide is released in response to repeated mechanical stimuli (to repeatedly induce the escape response). An analysis of known flp-18 receptors identifies npr-5 as a receptor whose mutation phenocopies flp-18. In addition, loss of npr-5 suppresses the flp-18 overexpression effects on curvature, head movements, and omega turns. Overexpression of npr-5 under its own promoter causes increased tap-induced curvature. Overexpression in muscle causes a basal increase in curvature. Finally, the authors use GCaMP imaging in muscle to show that FLP-18 overexpression causes increased muscle depolarization, dependent on npr-5 and egl-30.

Overall, this is an interesting paper and the experiments are for the most part convincing, especially the genetic/behavioral analysis. I have a few concerns:

1. The reduction in FLP-18::VENUS signal over hours of repeated tap stimuli is consistent with release of FLP-18 during the escape response, but given that there is no increase in coelomocyte signal, the results seem a bit ambiguous. Could the authors perform this experiment in a unc-31 neuropeptide release-deficient mutant to ensure that the signal change is due to peptide release? Another possible control strain could also be RIM::HisCl to prevent depolarization during tap.

2. The effects of cex-1::FLP-18 expression are only provided in a video format. It would be worthwhile to quantify these results and perform statistical analysis to test whether the results are robust. I would also suggest making and analyzing gcy-13::FLP-18 to specifically assess the role of RIM-released FLP-18. Adding this aspect of cell specificity to the manuscript would strengthen the study.

3. The muscle GCaMP imaging is interesting, but I’m slightly concerned about the quantification. The authors observe increased muscle GCaMP signal in FLP-18 overexpression animals, but there is no control signal to normalize to. Can the authors perform ratiometric imaging (normalizing the GCaMP signal to a co-expressed red fluorophore)? This would rule out the possibility that flp-18 overexpression simply enhances the GCaMP expression levels.

4. Can the authors make a flp-18;npr-5 double mutant to test for additive vs non-additive effects.

Minor concerns:

1. It would be helpful to cite other examples of co-tranmsmission in C. elegans and compare the models arising from these different studies. One example is serotonin and nlp-3 co-release from HSN.

Reviewer #3: In the paper “Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response”, the authors show that release of FLP-18 during touch-evoked reversals acts through NPR-5 to increase intracellular calcium release in the neck and body muscles. This, in combination with tyramine release from RIM, enhances the overall escape response through increased bending of the head and the body. The authors show that overexpression of FLP-18 results in increased omega turn closure rates and head oscillations, and that this is blocked by npr-5 mutation. Overall, this is an interesting paper that presents a rather complete genetic pathway but a few additional experiments could be added to help support their claims.

Major revisions:

• The order in which data are presented in the figures is at odds with the flow of the main text of the manuscript. Rather than the manuscript walking through each figure, references to each figure occur in many parts of the paper. This makes the manuscript somewhat cumbersome to read, so I would recommend reorganizing the data presentation in the figures to match the logic of the manuscript.

• The authors emphasize in the title as well as the introduction/discussion the novelty of elucidating the various, sometimes opposing, roles of co-transmission of neuropeptide (FLP-18) and monoamine (tyramine). However, the bulk of their data only addresses the contribution of FLP-18 to escape behavior and discussion of tyramine is limited mostly to literature references. Data addressing tyramine can be found in figure 1, where a tdc-1 mutant seems to complete its reversal faster than wild-type (Fig. 1a) but does not show a difference in reversal velocity or forward run velocity (Fig. 1c-d). This is in contrast to the flp-18 mutant, which has decreased velocity in both reversal and forward run. These data would imply that FLP-18 and tyramine release both work in separate pathways, at least in this aspect of the escape behavior. I would like to see some data regarding the involvement of tyramine signaling in their other assays to demonstrate its interaction with FLP-18. For example, does a tdc-1; flp-18 double mutant behave more like tdc-1 or flp-18 single mutant in terms of open omega turns and head movement? Does a tdc-1 mutation affect muscle calcium levels? If they find tdc-1 phenotypes in their assays, can they be rescued by RIM expression?

• The authors mention a few times that the forward run velocity data represents a change in the internal state of the animal, and represents a state of arousal. Their evidence for this is the ~3 minute increase in velocity post-reversal, which they call a “forward run”. However, this specific behavior is not investigated in most of the later experiments with FLP-18 overexpression or npr-5 mutation. I would be interested to see if FLP-18 overexpression increases either the velocity or duration of the forward run.

• Figure 5 explores possible FLP-18 receptors to determine which one is acting in their behavioral pathway. The authors demonstrate that FLP-18 overexpression phenotypes can be blocked by npr-5 mutation. However, none of their data includes single npr-5 mutant behavior without FLP-18 overexpression. This is important to illustrate the nature of their interaction, and how much the npr-5 mutation contributes to the phenotype alone.

Minor revisions:

• The figure references are inconsistently formatted (e.g. 217: “Fig. 3, f”, vs. 225: “Fig. 5d” )

• Lines 114-115 read: “wild-type animals exhibited a markedly elevated forward locomotion rate for approximately 3 minutes (Fig. S1) – a behavior we termed the ‘forward run’”. However, the figure 1 legend, lines 778-779, states: “(d) Mean locomotion velocity during the forward run phase (t = 7-10s)”. Clarify whether “forward run” refers to either a three-minute period or a 7-10s period.

• Figure S2b is missing, and it appears that the figure legend for S2b actually refers to S2a, which is the only panel pictured.

• Lines 226-228 read: “the proportion of open omega turns made by npr-5; FLP-18(+++) animals is significantly increased and similar to the npr-5 single mutants (Fig. 5e)”. While this trend is as stated, the % open omega turns in Fig. 5e by the npr-5; FLP-18(+++) animals is ~65% but in Fig. 3g, the % open omega turns for the npr-5 single mutants is much lower, at around 40%. The WT response remains at around 20% for both graphs.

• In figure 7a, I would be interested in seeing the calcium concentration in body wall muscles that oppose each other in the sinusoidal wave, since one side is contracted and the other, relaxed. With this kind of analysis the authors could see if FLP-18 overexpression increases the calcium concentration but the differential concentration between opposing sides is maintained, or if calcium concentration is increased to the extent that the differential is reduced. The images could also be presented with a colored heatmap representing calcium concentration instead of grayscale to increase the dynamic range of the representative images, which on my screen appear to be saturated in spots.

• In the Molecular Biology and Transgenics section, clarify how the high-expressing vs. low-expressing FLP-18 lines were made. Adding plasmid concentrations to the strain list would help with this.

• Lines 400 – 402 read: “FLP-18 transgenic strains were created by amplifying a 5.8kb sequence of genomic DNA beginning 3.3kb upstream of the open reading frame and containing the flp-18 coding region as well as the 3’ UTR. The extrachromosomal array was stably integrated…”. Please indicate specifically that this region of DNA was cloned into a plasmid and injected. As is it sounds like the amplified PCR fragment was injected. The same applies to the NPR-5 transgenic process.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Gregory P Copenhaver, Kaveh Ashrafi

11 Feb 2022

Dear Dr %Alkema%,

We are pleased to inform you that your manuscript entitled "Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response." has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Kaveh Ashrafi

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The revised version of the manuscript satisfactorily addresses all my initial concerns and I think also the ones from the other reviewers.

Reviewer #2: The authors have adequately addressed my concerns.

Reviewer #3: The authors have addressed all of my concerns. Congratulations on an interesting paper

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-01371R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Kaveh Ashrafi

27 Feb 2022

PGENETICS-D-21-01371R1

Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response.

Dear Dr Alkema,

We are pleased to inform you that your manuscript entitled "Co-transmission of neuropeptides and monoamines choreograph the C. elegans escape response." has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Escape behavior in tdc-1;flp-18 double mutants.

    (A and B) Behavioral schematic (top) and velocity traces (bottom) of animals executing the escape response. (A) In wild type animals, forward run velocity remains elevated for approximately 3 minutes after the escape response. Dotted line marks pre-stimulus baseline. (B) Comparison of tdc-1;flp-18 double mutants to the velocity traces presented in Fig 1B. (A-B) Negative velocity indicates backward locomotion. Solid line in trace represents mean velocity, shaded area indicates standard error of the mean. (C-F) Quantification of escape behavior in flp-18, tdc-1, and tdc-1;flp-18 mutant animals. See Fig 3 for details. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.005 = **, P<0.0005 = ***, P<0.0001 = ****). Sample size: (A) n = 14 independent trials with 20 worms recorded during each trial. (B) n = # of animals. Wild type, flp-18, and tdc-1 values are reported in Fig 1. tdc-1;flp-18 (n = 204). (C-E), n = # of experiments, 20 worms per experiment. Wild type (n = 12), flp-18 (n = 11), tdc-1 (n = 12), tdc-1;flp-18 (n = 11). (F) n = # of animals. Wild type (n = 88), flp-18 (n = 58), tdc-1 (n = 60), tdc-1;flp-18 (n = 60).

    (TIF)

    S2 Fig. Expression pattern and behavioral analysis of Pcex-1::FLP-18::SL2::mCherry.

    (A) Confocal z-projection of zfEx528[Pcex-1::FLP-18::SL2::mCherry showing detail of head neurons. Cell bodies are labeled, neurons were identified based on anatomical position. (B-D) Analysis of FLP-18 overexpression from endogenous (Pflp-18) and cell specific (Pcex-1) promotors. Spontaneous reversal frequency (B), mean body curvature averaged over 5 seconds prior to (C), or immediately following (D), a tap stimulus. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.0001 = ****). Sample size: (B-D) n = # of experiments, 20 animals per experiment. Wild type (n = 16), Pflp-18::FLP-18(+++) (n = 4), Pcex-1::FLP-18(+++) (n = 6).

    (TIF)

    S3 Fig. Animals overexpressing FLP-18 fail to suppress head oscillations during escape.

    Minimum intensity projections from video recordings of wild type (A) and FLP-18 overexpressing animals (B) after anterior touch. “start” indicates location of head when the animal was touched and initiated a reversal. The omega (Ω) symbol indicates the point where an omega turn was initiated, and the animal switched from reversal to forward motion. “end" indicates the position of the head at the end of the video. The head of the wild-type animal remains relaxed and follows the body during the reversal (A). The FLP-18(+++) overexpressing animal continues head oscillations during the reversal which are visible as the tip of the nose projecting out from the sides of the body and are indicated with red arrows (B). Scale bar = 100μm.

    (TIF)

    S4 Fig. Characterization of reversal behavior and body curvature in FLP-18 receptor mutants.

    (A and B) Quantification of mean body curvature averaged over 5 seconds prior to a tap stimulus (A) or immediately following a strong tap stimulus (B). (C and D) npr-5 but not npr-1 mutation suppresses high spontaneous reversal frequency in low oxygen conditions. Quantification of spontaneous reversal frequency in ambient oxygen (C) or in low oxygen conditions (D). Mean number of spontaneous reversals per minute per worm averaged over 3 minutes as in Fig 5H. Ambient oxygen experiments (C) were conducted with a standard lid-covered plate in room air. Low-oxygen experiments (D) were conducted on a plate that had nitrogen gas injected into it with a 5ml syringe prior to placing a lid. After lid placement, both conditions were allowed to acclimate for 5 minutes prior to recording. Graphs represent mean ± SEM, significance was calculated using ANOVA with Šidák’s multiple comparison correction (P<0.05 = *, P<0.005 = **, P<0.0001 = ****). Sample sizes (# of experiments, 20 animals per experiment): (A-B) wild type (n = 22), npr-1 (n = 14), npr-4 (n = 12), npr-5 (n = 13). (C) wild type (n = 26), flp-18 (n = 28), npr-1 (n = 14), npr-4 (n = 23), npr-5 (n = 17). (D) wild type (n = 12), FLP-18(+++) (n = 12), npr-1; FLP-18(+++) (n = 15), npr-5; FLP-18(+++) (n = 13).

    (TIF)

    S5 Fig. Muscle::mCherry levels are unaffected by mutations in FLP-18 signaling.

    Quantification of mCherry fluorescence in animals expressing the transgene zfEx813[Pmyo-3::NLSwCherry::SL2::GCaMP6] (muscle::GCaMP) in the genetic backgrounds analyzed in Fig 7B. Because the FLP-18 overexpression line (zfIs149[Pflp-18(3kb)::mCherry::SL2::FLP-18]) carries an mCherry transcriptional reporter, mutant lines are compared to their respective control background, muscle::GCaMP (A) or muscle::GCaMP; FLP-18(+++) (B). (C) Fluorescent micrograph showing mCherry, GCaMP and merged signals of a animals expressing zfIs149 alone (bottom, FLP-18(+++)) or in combination with zfEx813 (top, muscle::GCaMP; FLP-18(+++)). Scale bar = 200 μm. Graphs represent mean ± SEM, significance was calculated using ANOVA with Dunnett’s multiple comparison correction (P>0.05 = ns). Sample sizes (# animals): (A) muscle::GCaMP (n = 46), flp-18 (n = 30), npr-5 (n = 23), egl-30 (n = 15). (B) FLP-18(+++) (n = 39), npr-5; FLP-18(+++) (n = 21), egl-30; FLP-18(+++) (n = 30).

    (TIF)

    S1 Data. Raw data used to generate all graphs in the manuscript.

    The compressed folder contains 11 excel files each corresponding to a figure which is specified in the filename. Excel files are broken down into multiple sheets, each containing the data for an individual panel of a figure.

    (ZIP)

    S1 Video. Locomotion of Pflp-18_FLP-18(+++): overexpression of FLP-18 driven by the endogenous promotor results in uncoordinated locomotion, deep body bends and increased reversals.

    (MP4)

    S2 Video. Locomotion of Pcex-1_FLP-18(+++): overexpression of FLP-18 from the cex-1 drives expression in the RIM, AVA, and AVD and results in uncoordinated locomotion, deep body bends and increased reversals, similar to overexpression from the endogenous promoter.

    (MP4)

    S3 Video. Touch response in wild type.

    The escape response to anterior touch in wild type animals consists of a reversal during which head movements are suppressed followed by an omega turn and resumption of head movements and forward locomotion in the opposite direction. An eyelash is used to gently touch the animal behind the head to trigger the escape response.

    (MP4)

    S4 Video. Touch response in FLP-18(+++).

    The escape response in animals overexpressing FLP-18 results in deeper body bends and a failure to suppress exploratory head movements while reversing. An eyelash is used to gently touch the animal behind the head to trigger the escape response.

    (MP4)

    Attachment

    Submitted filename: Rebuttal MA.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES